A
Alnylam Pharmaceuticals
Cambridge, United States
Founded 2002 NASDAQ: ALNY
About
Leader in RNAi therapeutics using lipid nanoparticle delivery for genetic diseases
Company Details
- Type
- public
- Employees
- 2400+
- Funding
- Public
Key Products
- Onpattro
- Givlaari
- Oxlumo